5-hydroxytriptamine 2 receptor antagonist sarpogrelate reduces urinary and plasma levels of thromboxane A2 and urinary albumin excretion in type 2 diabetic patients

Non-selective endothelin receptor antagonist reduces diet-induced hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice.ET-1 effect through the ETB receptor plays an important role in atherogenesis

Thromboxane A[2] receptor antagonist (ONO 3708) protects from liver damage induced by cholestasis and ischemia-reperfusion

The clinicopathological significance of determination of urinary leukotriene E[4] and 11-dehydrothromboxane B[2] in patients with bronchial asthma

A CXC chemokine receptor, CXCR5/BLR1, is a novel and specific coreceptor for human immunodeficiency virus type 2